What is Elevance Health's D&A?

Elevance Health (ELV) reported D&A of $354M in Q1 2026.

How has Elevance Health's D&A changed year-over-year?

Elevance Health's D&A decreased by 5.1% year-over-year, from $373M to $354M.

What is the long-term trend for Elevance Health's D&A?

Over 4 years (2021 to 2025), Elevance Health's D&A has grown at a 4.4% compound annual growth rate (CAGR), from $1.3B to $1.55B.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Elevance Health ELV D&A

D&A at other companies

HumanaHUM

$183M-8.5%

CVS HealthCVS

$1.12B-3.4%

UnitedHealth GroupUNH

$1.03B-3.0%

CenteneCNC

$300M-4.5%

Molina HealthcareMOH

$39M-18.8%

Oscar HealthOSCR

$7.02M+4.3%

Other financials

Income statement

See full

Revenue$50.2B+2.6%

Gross profit$44.7B+1.8%

Net income$1.8B-19.2%

EPS (diluted)$8.00-16.8%

Balance sheet

See full

Cash & equivalents$9.7B+28.8%

Total debt$31.5B+11.0%

Total equity$43.9B+3.3%

Total assets$125.83B+5.1%

Cash flow

See full

Operating cash flow$4.3B+326%

CapEx$235.0M+19.9%

Free cash flow$4.1B+399%

Valuation

See full

Market cap$84.11B-0.6%

Enterprise value$105.95B+0.4%

P/E16×+1.7×

P/S0.4×0.0×

Profitability

See full

Gross margin89.2%+0.6pp

Net margin2.6%-0.6pp

FCF margin3.3%+1.3pp

Returns & leverage

See full

Return on equity12.1%-2.1pp

Debt / equity0.7×+0.1×

Current ratio1.5×0.0×

Where this comes from

Reported directly by Elevance Health in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAmortizationAndAccretionNet.

The official record: Elevance Health’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elevance Health's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Elevance Health's D&A?: Elevance Health (ELV) reported D&A of $354M in Q1 2026.
How has Elevance Health's D&A changed year-over-year?: Elevance Health's D&A decreased by 5.1% year-over-year, from $373M to $354M.
What is the long-term trend for Elevance Health's D&A?: Over 4 years (2021 to 2025), Elevance Health's D&A has grown at a 4.4% compound annual growth rate (CAGR), from $1.3B to $1.55B.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.